World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
64
Citations
9917
World Ranking
9933
National Ranking
4345

Overview

Peter C. Keng is affiliated with the University of Rochester in the United States. Their research primarily focuses on the field of Medicine, with significant work conducted in the subfields of Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism, Immunology, and Psychiatry and Mental Health.

The scientist's recent papers cover a range of topics related to cancer biology and treatment resistance. Notable publications include:

  • Retraction notice to "FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cells" (2021) published in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  • Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancer (2020) published in The Prostate
  • Corrigendum to "In vitro-induced M2 type macrophages induces the resistance of prostate cancer cells to cytotoxic action of NK cells" (2020) published in Experimental Cell Research
  • Retraction Note: Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling (2021) published in Journal of Molecular Medicine
  • Retraction notice to "Neuroendocrine differentiation contributes to radioresistance development and metastatic potential increase in non-small cell lung cancer" (2021) published in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

The scientist's frequent co-authors include:

  • Yuhchyau Chen
  • Soo Ok Lee
  • Xiaohong Chen
  • Mingjing Shen
  • Ying Tsai

Peter C. Keng's work has appeared in publication venues such as UNC Libraries, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, The Prostate, Experimental Cell Research, and Journal of Molecular Medicine.

The main research topics covered by Peter C. Keng's work include:

  • Prostate Cancer Treatment and Research
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Hormonal and reproductive studies
  • Immune cells in cancer
  • Cancer Cells and Metastasis
  • Cancer, Stress, Anesthesia, and Immune Response

Best Publications

  • Sigma-2 receptors as a biomarker of proliferation in solid tumours.

    K T Wheeler;L M Wang;C A Wallen;S R Childers

  • Antioxidant properties of quercetin.

    Mei Zhang;Steven G. Swarts;Liangjie Yin;Chaomei Liu

  • Tumor Necrosis Factor-α Increases Circulating Osteoclast Precursor Numbers by Promoting Their Proliferation and Differentiation in the Bone Marrow through Up-regulation of c-Fms Expression

    Zhenqiang Yao;Ping Li;Qian Zhang;Edward M. Schwarz

  • Ataxia Telangiectasia Mutated (ATM) and ATM and Rad3-related Protein Exhibit Selective Target Specificities in Response to Different Forms of DNA Damage

    Christopher E. Helt;William A. Cliby;Peter C. Keng;Robert A. Bambara

  • Effect of Diethyldithiocarbamate on cis-Diamminedichloroplatinum(II)-induced Cytotoxicity, DNA Cross-Linking, and γ-Glutamyl Transpeptidase Inhibition

    Donald L. Bodenner;Peter C. Dedon;Peter C. Keng;Richard F. Borch

  • Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate

    Donald L. Bodenner;Peter C. Dedon;Peter C. Keng;Janet C. Katz

  • Characterization of Two Major Populations of Lung Fibroblasts: Distinguishing Morphology and Discordant Display of Thy 1 and Class II MHC

    Richard P. Phipps;David P. Penney;Peter Keng;Helen Quill

  • Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle.

    Yin Chang Liu;Robert L. Marraccino;Peter C. Keng;Robert A. Bambara

  • ABSENCE OF RADIATION-INDUCED G1 ARREST IN TWO CLOSELY RELATED HUMAN LYMPHOBLAST CELL LINES THAT DIFFER IN P53 STATUS

    John B. Little;Hatsumi Nagasawa;Peter C. Keng;Yongjia Yu

  • The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress.

    Michael A. O'Reilly;Rhonda J. Staversky;Richard H. Watkins;Christina K. Reed

  • Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor

    Kuang-Hsiang Chuang;Saleh Altuwaijri;Saleh Altuwaijri;Gonghui Li;Gonghui Li;Jiann-Jyh Lai

  • Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.

    David W. Scott;Daniella Livnat;Christopher A. Pennell;Christopher A. Pennell;Peter Keng

  • Passive Mechanical Behavior of Human Neutrophils: Effects of Colchicine and Paclitaxel

    Mientao A. Tsai;Richard E. Waugh;Peter C. Keng

  • Flow cytometric analysis to detect pathogens in bacterial cell mixtures using semiconductor quantum dots.

    Megan A Hahn;Peter C Keng;Todd D Krauss

  • Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment.

    Weimin Sun;Wei Wang;Jung Kim;Peter Keng

  • Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression

    Miao-Fen Chen;Miao-Fen Chen;Peter C. Keng;Hungyi Shau;Chun-Te Wu

  • Evidence that DNA damage detection machinery participates in DNA repair.

    Christopher E Helt;Wensheng Wang;Peter C Keng;Robert A Bambara

  • Antioxidants reduce consequences of radiation exposure.

    Paul Okunieff;Steven Swarts;Peter Keng;Weimin Sun

  • Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels

    LiJun Xu;LiJun Xu;XiaoDong Chen;XiaoDong Chen;MingJing Shen;MingJing Shen;Dong-Rong Yang

  • Relationship between γ-ray-induced G2/M Delay and Cellular Radiosensitivity

    H. Nagasawa;P. Keng;R. Harley;W. Dahlberg

Frequent Co-Authors

Paul Okunieff
Paul Okunieff University of Florida
Michael A. O'Reilly
Michael A. O'Reilly The University of Texas MD Anderson Cancer Center
Edith M. Lord
Edith M. Lord University of Rochester Medical Center
Robert A. Bambara
Robert A. Bambara University of Rochester
Richard P. Phipps
Richard P. Phipps University of Rochester
John B. Little
John B. Little Harvard University
Hatsumi Nagasawa
Hatsumi Nagasawa Colorado State University
Philip Rubin
Philip Rubin University of Rochester Medical Center
Chawnshang Chang
Chawnshang Chang University of Rochester Medical Center
James Palis
James Palis University of Rochester Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Peter C. Keng

Trending Scientists

Recently Published Articles